Table 2.
Characteristic | Micromethod | Immunoglobulin M Trypomastigote Excreted-Secreted Antigen–Blot | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Cord Blood | 1-Mo Blooda | Cumulative | Cord Blood | 1-Mo Blooda | Cumulative | |||||||
Neg | Pos | Neg | Pos | Neg | Pos | Neg | Pos | Neg | Pos | Neg | Pos | |
Infant status | ||||||||||||
Uninfected | 431 | 0 | 301 | 0 | 445 | 0 | 377 | 2 | 275 | 2 | 399 | 4 |
Infected | 30 | 6 | 20 | 7 | 25 | 13 | 15 | 21 | 14 | 12 | 10 | 28 |
Performance % [95% CI] | ||||||||||||
Sensitivity | 16.7 | [6, 33] | 25.9 | [11, 46] | 34.2 | [20, 51] | 58.3 | [41, 75] | 46.2 | [27, 67] | 73.7 | [57, 87] |
Specificity | 100 | [99, 100] | 100 | [99, 100] | 100 | [99, 100] | 99.5 | [98, 100] | 99.3 | [97, 100] | 99.0 | [97, 100] |
PPV | 100 | [54, 100] | 100 | [59, 100] | 100 | [75,100] | 91.3 | [72, 99] | 85.7 | [57, 98] | 87.5 | [71, 96] |
NPV | 93.5 | [91, 96] | 93.8 | [91, 96] | 94.7 | [92, 97] | 96.2 | [94, 98] | 95.2 | [92, 97] | 97.6 | [96, 99] |
Quantitative polymerase chain reaction | ||||||||||||
Cord Blood | Umbilical Tissue | 1-Mo Blooda | Cumulative | |||||||||
Neg | Pos | Neg | Pos | Neg | Pos | Neg | Pos | |||||
Infant status | ||||||||||||
Uninfected | 390 | 10 | 81 | 1 | 257 | 0 | 411 | 11 | ||||
Infected | 12 | 24 | 11 | 23 | 6 | 19 | 6 | 32 | ||||
Performance % [95% CI] | ||||||||||||
Sensitivity | 66.7 | [49, 81] | 67.6 | [49, 83] | 76.0 | [55, 91] | 84.2 | [69, 94] | ||||
Specificity | 97.5 | [95, 99] | 98.8 | [93, 100] | 100 | [99, 100] | 97.4 | [95, 99] | ||||
PPV | 70.6 | [53, 85] | 95.8 | [79, 100] | 100 | [82, 100] | 74.4 | [59, 86] | ||||
NPV | 97.0 | [95, 98] | 88.0 | [80, 94] | 97.7 | [95, 99] | 98.6 | [97, 99] | ||||
Conventional serology at 6 mo or older | ||||||||||||
IHA ≥16 at 6 mo | IHA ≥128 at 6 mo | ELISA at 6 mo | IHA ≥16 at 9 mo | ELISA at 9 mo | ||||||||
Neg | Pos | Neg | Pos | Neg | Pos | Neg | Pos | Neg | Pos | |||
Infant status | ||||||||||||
Uninfected | 203 | 50 | 245 | 8 | 159 | 49 | 166 | 7 | 163 | 3 | ||
Infected | 1 | 14 | 6 | 9 | 0 | 14 | 0 | 12 | 0 | 12 | ||
Performance % [95% CI] | ||||||||||||
Sensitivity | 93.3 | [68, 100] | 60.0 | [32, 84] | 100 | [77, 100] | 100 | [74, 100] | 100 | [74, 100] | ||
Specificity | 80.2 | [75, 85] | 96.8 | [94, 99] | 76.4 | [70, 82] | 96.0 | [92, 98] | 98.2 | [95, 100] | ||
PPV | 21.9 | [13, 34] | 52.9 | [28, 77] | 22.2 | [13, 34] | 63.2 | [38, 84] | 80.0 | [52, 96] | ||
NPV | 99.5 | [97, 100] | 97.6 | [95, 99] | 100 | [98, 100] | 100 | [98, 100] | 100 | [98, 100] |
Abbreviations: CI, confidence interval; ELISA, enzyme-linked immunosorbentassay; IHA, indirect hemagglutination assay; NPV, negative predictive value; PPV, positive predictive value.
aSix infants treated before 1 month of age excluded from 1-month specimen analyses.